1. Home
  2. LRHC vs ADIL Comparison

LRHC vs ADIL Comparison

Compare LRHC & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRHC
  • ADIL
  • Stock Information
  • Founded
  • LRHC 2004
  • ADIL 2010
  • Country
  • LRHC United States
  • ADIL United States
  • Employees
  • LRHC N/A
  • ADIL N/A
  • Industry
  • LRHC
  • ADIL Biotechnology: Pharmaceutical Preparations
  • Sector
  • LRHC
  • ADIL Health Care
  • Exchange
  • LRHC Nasdaq
  • ADIL Nasdaq
  • Market Cap
  • LRHC 7.3M
  • ADIL 7.7M
  • IPO Year
  • LRHC 2023
  • ADIL 2018
  • Fundamental
  • Price
  • LRHC $3.89
  • ADIL $0.32
  • Analyst Decision
  • LRHC
  • ADIL Strong Buy
  • Analyst Count
  • LRHC 0
  • ADIL 2
  • Target Price
  • LRHC N/A
  • ADIL $4.75
  • AVG Volume (30 Days)
  • LRHC 17.3K
  • ADIL 440.9K
  • Earning Date
  • LRHC 11-19-2025
  • ADIL 11-13-2025
  • Dividend Yield
  • LRHC N/A
  • ADIL N/A
  • EPS Growth
  • LRHC N/A
  • ADIL N/A
  • EPS
  • LRHC N/A
  • ADIL N/A
  • Revenue
  • LRHC $78,037,079.00
  • ADIL N/A
  • Revenue This Year
  • LRHC N/A
  • ADIL N/A
  • Revenue Next Year
  • LRHC N/A
  • ADIL N/A
  • P/E Ratio
  • LRHC N/A
  • ADIL N/A
  • Revenue Growth
  • LRHC 54.92
  • ADIL N/A
  • 52 Week Low
  • LRHC $3.66
  • ADIL $0.22
  • 52 Week High
  • LRHC $95.20
  • ADIL $1.30
  • Technical
  • Relative Strength Index (RSI)
  • LRHC 35.23
  • ADIL 49.53
  • Support Level
  • LRHC $3.66
  • ADIL $0.31
  • Resistance Level
  • LRHC $4.41
  • ADIL $0.38
  • Average True Range (ATR)
  • LRHC 0.46
  • ADIL 0.02
  • MACD
  • LRHC -0.13
  • ADIL -0.00
  • Stochastic Oscillator
  • LRHC 21.92
  • ADIL 54.41

About LRHC La Rosa Holdings Corp.

La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.

About ADIL Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.

Share on Social Networks: